Literature DB >> 16395699

Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China.

Xue-Hong Zhang1, Gabriella Andreotti, Yu-Tang Gao, Jie Deng, Enju Liu, Asif Rashid, Kai Wu, Lu Sun, Lori C Sakoda, Jia-Rong Cheng, Ming-Chang Shen, Bing-Sheng Wang, Tian-Quan Han, Bai-He Zhang, Gloria Gridley, Joseph F Fraumeni, Ann W Hsing.   

Abstract

Biliary tract cancers, encompassing tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater, are rare but highly fatal malignancies. Apart from gallstones, etiologic factors for biliary tract cancer are not clearly defined. Several epidemiologic studies have suggested that consumption of tea, especially green tea, is protective against a variety of cancers, including gastrointestinal malignancies. As part of a large population-based case-control study of biliary tract disease in Shanghai, China, we evaluated the effects of tea consumption on the risk of biliary tract cancers and biliary stones. The study included 627 incident cases with biliary tract cancer, 1,037 cases with biliary stones and 959 randomly selected controls. Study subjects were interviewed to ascertain data on demographic, medical and dietary factors, including tea consumption. Forty-one percent of the controls were ever tea drinkers, defined as those who consumed at least 1 cup of tea per day for at least 6 months. After adjustment for age, education and body mass index, among women, ever tea drinkers had significantly reduced risks of biliary stones (OR = 0.73, 95% CI = 0.54-0.98) and gallbladder cancer (OR = 0.56, 95% CI = 0.38-0.83). The inverse relationship between tea consumption and gallbladder cancer risk was independent of gallstone disease. Among men, tea drinkers were more likely to be cigarette smokers, and the risk estimates were generally below 1.0, but were not statistically significant. Further studies are needed to confirm these results in other populations and clarify the hormonal and other mechanisms that may be involved. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395699      PMCID: PMC2885773          DOI: 10.1002/ijc.21748

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

Review 1.  Tea consumption and cancer.

Authors:  S K Katiyar; H Mukhtar
Journal:  World Rev Nutr Diet       Date:  1996       Impact factor: 0.575

2.  Cancer incidence trends in urban shanghai, 1972-1994: an update.

Authors:  F Jin; S S Devesa; W H Chow; W Zheng; B T Ji; J F Fraumeni; Y T Gao
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

3.  Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy.

Authors:  Cynthia W Ko; Shirley A A Beresford; Scott J Schulte; Alvin M Matsumoto; Sum P Lee
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

4.  Rising incidence of biliary tract cancers in Shanghai, China.

Authors:  A W Hsing; Y T Gao; S S Devesa; F Jin; J F Fraumeni
Journal:  Int J Cancer       Date:  1998-01-30       Impact factor: 7.396

5.  Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.

Authors:  Y C Liang; S Y Lin-Shiau; C F Chen; J K Lin
Journal:  J Cell Biochem       Date:  1999-10-01       Impact factor: 4.429

6.  Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer.

Authors:  W A Zatonski; A B Lowenfels; P Boyle; P Maisonneuve; H B Bueno de Mesquita; P Ghadirian; M Jain; K Przewozniak; P Baghurst; C J Moerman; A Simard; G R Howe; A J McMichael; C C Hsieh; A M Walker
Journal:  J Natl Cancer Inst       Date:  1997-08-06       Impact factor: 13.506

Review 7.  Green tea and cancer in humans: a review of the literature.

Authors:  J L Bushman
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

8.  The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China.

Authors:  B T Ji; W H Chow; G Yang; J K McLaughlin; R N Gao; W Zheng; X O Shu; F Jin; J F Fraumeni; Y T Gao
Journal:  Cancer       Date:  1996-06-15       Impact factor: 6.860

9.  Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells.

Authors:  Tajamul Hussain; Sanjay Gupta; Vaqar M Adhami; Hasan Mukhtar
Journal:  Int J Cancer       Date:  2005-02-10       Impact factor: 7.396

10.  Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan.

Authors:  Y Ohno; K Wakai; K Genka; K Ohmine; T Kawamura; A Tamakoshi; R Aoki; M Senda; Y Hayashi; K Nagao
Journal:  Jpn J Cancer Res       Date:  1995-11
View more
  11 in total

1.  Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study.

Authors:  Sarah Nechuta; Xiao-Ou Shu; Hong-Lan Li; Gong Yang; Bu-Tian Ji; Yong-Bing Xiang; Hui Cai; Wong-Ho Chow; Yu-Tang Gao; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

2.  Tea consumption and risk of gallbladder cancer: A meta-analysis of epidemiological studies.

Authors:  Guangwei Zhu; Jin Hua; Zhijian Wang; Feifei She; Yanling Chen
Journal:  Mol Clin Oncol       Date:  2015-01-21

3.  Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.

Authors:  Ann W Hsing; Yan Bai; Gabriella Andreotti; Asif Rashid; Jie Deng; Jinbo Chen; Alisa M Goldstein; Tian-Quan Han; Ming-Chang Shen; Joseph F Fraumeni; Yu-Tang Gao
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

Review 4.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

5.  A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan.

Authors:  Yau-Chang Kuo; Chu-Ling Yu; Chen-Yu Liu; Su-Fen Wang; Pi-Chen Pan; Ming-Tsang Wu; Chi-Kung Ho; Yu-Shing Lo; Yi Li; David C Christiani
Journal:  Cancer Causes Control       Date:  2008-08-28       Impact factor: 2.506

Review 6.  Association between alcohol consumption and cancers in the Chinese population--a systematic review and meta-analysis.

Authors:  Ying Li; Huan Yang; Jia Cao
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

Review 7.  Tea consumption and the risk of biliary tract cancer: a systematic review and dose-response meta-analysis of observational studies.

Authors:  Jianping Xiong; Jianzhen Lin; Anqiang Wang; Yaqin Wang; Ying Zheng; Xinting Sang; Yiyao Xu; Xin Lu; Haitao Zhao
Journal:  Oncotarget       Date:  2017-06-13

8.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02

9.  Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China.

Authors:  Shih-Chen Chang; Asif Rashid; Yu-Tang Gao; Gabriella Andreotti; Ming-Chang Shen; Bin-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Lori C Sakoda; Michael F Leitzmann; Bingshu E Chen; Philip S Rosenberg; Jinbo Chen; Stephen J Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2008-03-28       Impact factor: 4.944

10.  Association between green tea/coffee consumption and biliary tract cancer: A population-based cohort study in Japan.

Authors:  Takeshi Makiuchi; Tomotaka Sobue; Tetsuhisa Kitamura; Junko Ishihara; Norie Sawada; Motoki Iwasaki; Shizuka Sasazuki; Taiki Yamaji; Taichi Shimazu; Shoichiro Tsugane
Journal:  Cancer Sci       Date:  2016-01       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.